Ciara Cleary

Patent Agent

+52 (55) 5047-7500 Ext. 3104

cc@cyslaw.mx

vCard vCard

Languages

Spanish . English . Irish . German

Education

A (Mod) Human Genetics, Trinity College Dublin

M.Sc. Genetics, University College London (UCL)

D. Medical University of Vienna, Austria (thesis defense pending).

ASSOCIATIONS

Ciara is a member of the Patent Department.

 

She joined the firm in 2014 and handles complex patent matters pertaining to the areas of biotechnology and pharmaceuticals.

 

Ciara studied her undergraduate degree at Trinity College Dublin, where she obtained an honors degree in Human Genetics. Then, she went on to complete her M.Sc. at University College London, specializing in molecular genetics. Prior to entering Calderon & de la Sierra, she carried out research for her Ph.D. at the Medical University of Vienna, with a focus on hematological malignancies.

Publications:

 

  • Cleary C, Kralovics R, Molecular basis and clonal evolution of myeloproliferative neoplasms, 2013, Clin Chem Lab Med 10: 1889-96

 

  • Rumi E et al, A novel germline JAK2 mutation in familial myeloproliferative neoplasms, 2014, Am J Hematol 1: 117-8

 

  • Klampfl T et al, Somatic mutations of calreticulin in myeloproliferative neoplasms, 2013, N Engl J Med 25: 2379-90

 

  • Kornienko, Aleksandra E. et al. “Long Non-Coding RNAs Display Higher Natural Expression Variation than Protein-Coding Genes in Healthy Humans.” Genome Biology 17 (2016).

 

  • Nivarthi H, Chen D, Cleary C, Kubesova B, Jäger R, Bogner E, et al. Thrombopoietin receptor is required for the oncogenic function of CALR mutants. Leukemia. 2016

 

Conferences:

 

  • European Hematology Association (EHA) Stockholm, Sweden June 2013 : Poster Presentation